Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ; Miller DH; Phillips JT; Hutchinson M; Havrdova E; Kita M; Yang M; Raghupathi K; Novas M; Sweetser MT; Viglietta V; Dawson KT; The New England Journal Of Medicine, 2012, vol. 367, issue 12, p 1087, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation